Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cisplatin measurement |
Component |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin poisoning |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Accidental cisplatin poisoning |
Causative agent (attribute) |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Intentional cisplatin poisoning |
Causative agent (attribute) |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
intoxication par la cisplatine d'intention indéterminée |
Causative agent (attribute) |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin adverse reaction |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Allergy to cisplatin |
Causative agent (attribute) |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin overdose (disorder) |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Accidental cisplatin overdose |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Intentional cisplatin overdose |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
surdose de cisplatine d'intention indéterminée |
Causative agent (attribute) |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin 1mg/mL infusion concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 1mg/mL infusion concentrate 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 1mg/mL infusion concentrate 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 500micrograms/mL infusion concentrate 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 50mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 1mg/mL infusion solution 200mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 10mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 50mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 10mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Product containing cisplatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin 50mg/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 100mg/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 50mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 10mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Cisplatin 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Accidental cisplatin poisoning |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Intentional cisplatin poisoning |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cis-platinum nephropathy |
Causative agent (attribute) |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
4 |
Cisplatin liposome (substance) |
Is a |
False |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Allergy to cisplatin |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cisplatin liposome (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
|
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Cis-platinum nephropathy |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
2 |
Cis-platinum nephropathy |
Causative agent (attribute) |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cisplatin 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cisplatin 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cisplatin (substance) |
Inferred relationship |
Some |
1 |